GlassScriptPhysician profile
Heidi C Shea
NPI 1578517926
$186,029.98
in general payments reported to CMS, 2019-2025
81 companies · $55K in 2025
The $55K reported for 2025 was more than what 96% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $12K · 2021: $20K · 2022: $32K · 2023: $17K · 2024: $25K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Consulting Fee: $27K · Food and Beverage: $11K · Honoraria: $7,200 · Travel and Lodging: $4,387 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,876.01 |
| Consulting Fee | $27,352.50 |
| Food and Beverage | $10,830.68 |
| Honoraria | $7,200.00 |
| Travel and Lodging | $4,386.66 |
| Education | $182.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $83,210.09 | 2019-2025 | Sogroya, Ozempic, Rybelsus |
| Neurocrine Biosciences, INC. | $25,077.28 | 2024-2025 | Crenessity |
| Rhythm Pharmaceuticals, INC. | $22,378.54 | 2021-2023 | Imcivree |
| Ascendis Pharma Endocrinology INC | $21,838.21 | 2022-2025 | Skytrofa, Yorvipath |
| Soleno Therapeutics, INC. | $7,610.14 | 2025 | Vykat Xr |
| Endo Pharmaceuticals INC. | $6,487.08 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $3,568.23 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $1,211.74 | 2019-2025 | Omnipod |
| Lilly USA, LLC | $1,092.51 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $1,049.02 | 2019-2025 | Evenity, Prolia, Tepezza |
| Mannkind Corporation | $955.82 | 2019-2025 | Afrezza |
| Xeris Pharmaceuticals, INC. | $856.66 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Abbvie INC. | $828.71 | 2019-2025 | Synthroid |
| Astrazeneca Pharmaceuticals LP | $736.43 | 2019-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $614.01 | 2019-2025 |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $604.05 | 2019-2025 | Jardiance |
| Medtronic, INC. | $554.78 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Radius Health, INC. | $543.97 | 2019-2024 | Tymlos |
| Abbott Laboratories | $521.07 | 2021-2025 | Freestyle Libre 3, Alinity, Freestyle Libre 2 |
| Amneal Pharmaceuticals LLC | $451.63 | 2019-2025 | Unithroid |
| Dexcom, INC. | $393.38 | 2019-2025 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $345.00 | 2019-2024 | Strensiq |
| Amarin Pharma, INC. | $311.33 | 2019-2023 | |
| Corcept Therapeutics | $299.90 | 2019-2025 | Korlym |
| Merck Sharp & Dohme LLC | $276.26 | 2019-2021 | |
| Pfizer INC. | $250.70 | 2019-2025 | |
| Ibsa Pharma INC. | $236.29 | 2019-2025 | Licart, Tirosint, Flector |
| Sequel Med Tech, LLC | $214.86 | 2025 | Twiist |
| Bayer Healthcare Pharmaceuticals INC. | $214.68 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $165.29 | 2019-2020 | |
| Horizon Therapeutics Plc | $155.73 | 2022-2023 | Tepezza |
| Cequr Corporation | $155.33 | 2022-2024 | Cequr Simplicity |
| Madrigal Pharmaceuticals | $153.49 | 2025 | Rezdiffra |
| Esperion Therapeutics, INC. | $148.32 | 2021-2024 | Nexletol |
| Sanofi Pasteur INC. | $120.19 | 2025 | |
| Amryt Pharma Holdings LTD | $119.79 | 2022-2023 | Mycapssa |
| Tolmar Pharmaceuticals, INC. | $118.41 | 2022 | |
| Avvisto Therapeutics, LLC | $106.41 | 2024-2025 | Cycloset |
| Valeritas, INC. | $91.82 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $91.31 | 2024 | |
| Eton Pharmaceuticals, INC. | $88.32 | 2020-2021 | |
| Shire North American Group INC | $87.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $85.96 | 2022 | |
| Zealand Pharma US, INC. | $84.29 | 2020-2021 | |
| Recordati_rare_diseases_inc. | $83.25 | 2025 | Isturisa |
| Beta Bionics, INC. | $82.74 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Kyowa Kirin, INC. | $80.31 | 2023-2025 | Crysvita |
| Companion Medical, INC. | $78.17 | 2019-2020 | |
| Acella Pharmaceuticals, LLC | $76.85 | 2023 | NP Thyroid 60 |
| Intuity Medical INC | $76.30 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Shield Therapeutics INC | $73.39 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $70.36 | 2020-2022 | |
| Ultragenyx Pharmaceutical INC. | $65.33 | 2021-2024 | Crysvita |
| Antares Pharma, INC. | $63.34 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $62.48 | 2022 | |
| Vistapharm, INC. | $56.60 | 2021 | |
| Boston Scientific Corporation | $49.55 | 2025 | Apollo Esg System |
| Ascensia Diabetes Care US INC. | $48.85 | 2021-2024 | |
| Strongbridge US INC. | $43.75 | 2019 | |
| Chiesi USA, INC. | $43.12 | 2024-2025 | Mycapssa |
| Alvogen INC | $39.22 | 2023-2024 | Teriparatide |
| Senseonics, Incorporated | $39.00 | 2019 | |
| Tolmar, INC. | $33.03 | 2023 | |
| Amphastar Pharmaceuticals, INC. | $32.07 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.00 | 2022 | |
| Renalytix Ai, INC. | $29.58 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Astellas Pharma US INC | $29.54 | 2025 | Veozah |
| Vivus LLC | $28.21 | 2021-2024 | Qsymia |
| Averitas Pharma INC. | $26.32 | 2025 | Qutenza |
| Medtronic Minimed, INC. | $26.30 | 2019-2020 | |
| Acerus Pharmaceuticals Corporation | $24.93 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $24.59 | 2023 | Triptodur |
| Sun Pharmaceutical Industries INC. | $21.88 | 2020 | |
| Verity Pharmaceuticals INC. | $21.13 | 2024 | Tlando |
| Althera Pharmaceuticals LLC | $19.86 | 2022 | |
| Echosens North America, INC. | $19.14 | 2025 | Fibroscan |
| Ipsen Biopharmaceuticals, INC | $14.34 | 2022 | |
| Aytu Biopharma, INC. | $11.59 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$55,774.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.